OncBioMune Pharmaceuticals, Inc 4
4 · OncBioMune Pharmaceuticals, Inc · Filed Mar 13, 2017
Insider Transaction Report
Form 4
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
- Other
Series B Preferred Stock
2017-03-10+2,892,000→ 2,892,000 total
Footnotes (1)
- [F1]Securities issued pursuant to the terms and conditions of a Contribution Agreement to the Property of Trust F/2868 entered into among OncBioMune Pharmaceuticals, Inc., Manuel Cosme Odabachian and Carlos Fernando Alaman Volnie dated March 10, 2017 as filed by the Issuer as Exhibit 10.1 to its Current Report on Form 8-K as filed with the SEC on March 13, 2017.